Rankings
▼
Calendar
ARGX FY 2023 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena
ARGX
argenx SE
$46B
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1.2B
+198.6% YoY
Gross Profit
$1.1B
90.4% margin
Operating Income
-$425M
-34.7% margin
Net Income
-$295M
-24.1% margin
EPS (Diluted)
$-5.16
Cash Flow
Operating Cash Flow
-$420M
Free Cash Flow
-$464M
Stock-Based Comp.
$233M
Balance Sheet
Total Assets
$4.5B
Total Liabilities
$445M
Stockholders' Equity
$4.1B
Cash & Equivalents
$2.0B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.2B
$411M
+198.6%
Gross Profit
$1.1B
$381M
+190.7%
Operating Income
-$425M
-$720M
+41.0%
Net Income
-$295M
-$710M
+58.4%
← Q4 2022
All Quarters
Q1 2023 →